Disease-modifying antirheumatic drugs and organising pneumonia
- PMID: 33408105
- PMCID: PMC7789045
- DOI: 10.1136/bcr-2020-238173
Disease-modifying antirheumatic drugs and organising pneumonia
Abstract
Organising pneumonia (OP) in rheumatoid arthritis (RA) may be part of pulmonary manifestation (disease related) or disease-modifying antirheumatic drugs (DMARDs) related. We report a case series of RA patients with DMARDs related OP. A 65-year-old woman developed OP 3 weeks after initiation of methotrexate (MTX). High-resolution CT (HRCT) scan of the thorax revealed bilateral consolidations in the lung bases. She had complete radiological resolution 6 months after corticosteroid therapy with cessation of MTX. The second case was of a 60-year-old woman on MTX with recent addition of leflunomide due to flare of RA. She developed worsening cough 4 months later and HRCT scan revealed consolidation in the left upper lobe with biopsy proven OP. She responded within 6 months of corticosteroid therapy with clinical and radiological resolution. This case series highlights that OP may developed with low-dose MTX (as early as 3 weeks) and leflunomide and the diagnosis requires a high index of suspicion.
Keywords: interstitial lung disease; respiratory medicine; rheumatoid arthritis; rheumatology.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Clinical Characteristics and Cytokine Profiles of Organizing Pneumonia in Patients with Rheumatoid Arthritis Treated with or without Biologics.J Rheumatol. 2016 Apr;43(4):738-44. doi: 10.3899/jrheum.151019. Epub 2016 Feb 1. J Rheumatol. 2016. PMID: 26834212
-
Cryptogenic organizing pneumonia (COP), as presentation of rheumatoid arthritis.Rheumatol Int. 2008 Nov;29(1):99-101. doi: 10.1007/s00296-008-0618-4. Epub 2008 May 24. Rheumatol Int. 2008. PMID: 18500458
-
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.Arthritis Rheum. 2001 Sep;44(9):1984-92. doi: 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B. Arthritis Rheum. 2001. PMID: 11592358 Clinical Trial.
-
A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature.Mod Rheumatol. 2008;18(1):60-6. doi: 10.1007/s10165-007-0004-1. Epub 2007 Dec 26. Mod Rheumatol. 2008. PMID: 18159567 Review.
-
[Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].Ryumachi. 1995 Aug;35(4):699-704. Ryumachi. 1995. PMID: 7482069 Review. Japanese.
References
-
- Güzel A, Köksal N, Gök A, et al. . Leflunomide-Induced interstitial lung disease: a case report. Eurasian J Pulmonol 2015;17:67–9. 10.5152/ejp.2014.93357 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous